What Are Ginsenoside Monomers?
Ginsenoside monomers usually refer to specific saponin compounds isolated from Panax genus plants, for example ginsenoside Rb1, ginsenoside Rg1, and so on. Also called individual ginsenosides, they are bioactive triterpenoid saponins that are related to the pharmacological effects of ginseng products.
From the perspective of materials chemistry, each ginsenoside monomer has a certain structure-function relationship: the differences in the attached sugars, stereochemistry, glycosidic bonds, and the aglycone backbone (such as protopanaxadiol (PPD) and protopanaxatriol (PPT)) will affect their solubility, stability, and activity. Therefore, reliable identification and quantification of the monomers is a prerequisite for quality control, standardization, and regulatory compliance of the herbal materials.
Fig.1 Ginsenosides are classified into four categories based on the structural characteristics of their core skeleton: PPD, PPT, oleanolic acid (OA), and ocotillol (OT)[1].
This article will present a comprehensive and systematic discussion of the definitions of these monomers, the challenges of identification and detection, and how to apply modern analytical chemistry techniques (mainly separation, spectroscopic detection, and method validation) to measure them reliably.
Alfa Chemistry also provides ginsenoside detection reference substances according to standards, most of which are extracted from natural ginseng.
| Catalog Number | Product Name | Price |
| ACM41753439 | Ginsenoside Rb1 | Inquiry |
| ACM11021139 | Ginsenoside Rb2 | Inquiry |
| ACM68406268 | Ginsenoside Rb3 | Inquiry |
| ACM55286745 | Ginsenoside rg2 | Inquiry |
| ACM14197605-1 | Ginsenoside Rg3 | Inquiry |
| ACM11021140 | Ginsenoside Rc | Inquiry |
| ACM115038421 | Ginsenoside f11 | Inquiry |
| ACM53963432-1 | Ginsenoside F1 | Inquiry |
| ACM62025494 | Ginsenoside F2 | Inquiry |
| ACM63223869 | Ginsenoside Rh1 | Inquiry |
| ACM93376728 | Ginsenoside-m6a | Inquiry |
| ACM39262141 | Ginsenoside Compound K | Inquiry |
| ACM112246158 | 20(R)-Ginsenoside Rh2 | Inquiry |
| ACM67400173 | (S)-Ginsenoside rh2 | Inquiry |
| ACM38243037 | 20(R)Ginsenoside rg3 | Inquiry |
| ACM7821332 | 20(S)-Ginsenoside rh2 | Inquiry |
| ACM78214332 | 20(S)-Ginsenoside Rh2 | Inquiry |
What Are the Chemical Structures of Ginsenoside Monomers?
Aglycone Backbone and Sugar Linkages
Ginsenosides all share a triterpenoid dammarane backbone. PPD-type (e.g., Rb1, Rb2, and Rc) and PPT-type (e.g., Rg1 and Re) ginsenosides differ by hydroxylation at C-20 and C-3 and C-6, respectively, while different patterns of glycosylation (number, position, and type of sugar units (glucose, rhamnose, and arabinose)) further contribute to the structural diversity. In addition, malonylation (e.g. malonyl ginsenosides) or acetylation may occur in crude ginseng extracts.
Isomers, Stereochemistry, and Processing Derivatives
In addition to the simple glycosides, there are also stereoisomers (e.g., 20(S) vs. 20(R) isomers), positional isomers (sugar at C3 vs. sugar at C20), and processing-derived derivatives (e.g., Rg3 and Rk1 formed upon digestion/hydrolysis). These structural subtleties point to the necessity of monomer identification: unless the method is carefully designed, closely related isomers may coelute or produce identical mass fragments.
Fig.2 Summary of different ginsenoside monomers targeting mito-ROS, mitoapoptosis, mito-bioenergetics, mito-biogenesis, mito-dynamics, and mitophagy[2].
How Are ginsenoside Monomers Isolated and Identified?
Step 1. Sample Preparation - Extraction and Purification
The first step is to isolate ginsenoside monomers from ginseng roots, extracts, or other matrices. The standard operating procedures are as follows:
- Ginseng powder (or extract) is extracted with an aqueous organic solvent (e.g., 70% methanol) under ultrasonic or reflux conditions.
- Filtration and centrifugation are then performed, and solid-phase extraction (SPE) or liquid-liquid extraction may be used to reduce matrix interferences. For plasma or biological fluids, protein precipitation and SPE extraction can be used.
- If necessary, fractionation (e.g., open-column chromatography) can be performed to isolate individual monomers for reference materials or structural elucidation.
Alfa Chemistry emphasizes that extraction conditions (solvent composition, time, and temperature) must be optimized and documented, as glycoside conversion or degradation may occur.
Step 2: Chromatographic Separation (HPLC/UHPLC/2D-LC)
Because ginsenoside monomers are structurally similar and sometimes exist as isomers, traditional one-dimensional liquid chromatography (1D-HPLC) may not be able to adequately separate them. Commonly used separation methods include:
- Conventional liquid chromatography (HPLC) using a C18 column with UV detection (203 nm), which is an older method.
- Ultra-high performance liquid chromatography (UHPLC), which uses smaller particle size columns and shorter run times to improve resolution and throughput.
- Two-dimensional liquid chromatography (2D-LC) can further separate coeluting isomers (e.g., heart-cutting 2D methods), as reported for the separation of ginsenosides Rb1/Rb2/Rc.
Alfa Chemistry recommends considering the mobile phase composition (typically water plus formic acid or phosphoric acid, followed by acetonitrile or methanol), column temperature, flow rate, and gradient when designing a method. These parameters can significantly affect the separation of late-eluting or isomeric ginsenosides.
Fig.3 Reverse phase high performance liquid chromatography (RP-HPLC) was used to separate, purify and quantitatively analyze ginsenoside F5 and F3 isomers in crude extract of Panax ginseng flower buds (CEFBPG)[3].
Step 3: Spectroscopic Detection - UV, Evaporative Light Scattering Detector (ELSD), Tandem Mass Spectrometry (MS/MS)
After chromatographic separation, detection can be performed by the following methods:
- UV absorbance at approximately 203 nm (saponins absorb weakly, so sensitivity is limited).
- Evaporative Light Scattering Detector (ELSD) for non-chromogenic ginsenosides (for relative quantification).
- Mass spectrometry (MS) or tandem mass spectrometry (MS/MS) detection (currently the most robust and reliable methods) is used for structure-specific, highly sensitive, and quantitative analysis. For example, UHPLC-MS/MS MRM (multiple reaction monitoring) was performed on 26 ginsenosides, demonstrating good stereoisomer resolution.
- High-resolution mass spectrometry (QTOF) is used for structural elucidation of unknown ginsenosides and their adducts (e.g., in processed ginseng).
When regulatory or pharmacokinetic precision is required, Alfa Chemistry recommends LC-MS/MS for monomeric quantification; UV/ELSD may be sufficient for routine quality control but has limitations in isomer resolution and sensitivity.
Step 4 Structure Identification - MS Fragmentation and Reference Standards
For ginsenoside monomers, structure confirmation relies on:
- Accurate mass measurement (e.g., precursor ion + adduct, such as [M + Na]+)—in one study, G-Rg1 had an m/z of 800.4922, and the sodium adduct had an m/z of 823.4827.
- MS/MS fragmentation pattern: sugar group loss (e.g., 162 Da for glucose), dehydration, rearrangement, and characteristic aglycone fragmentation.
- Retention time matching with authentic standards, and co-injection whenever possible.
- For isomers: Comparison of retention behavior and stereoisomer separation (e.g., Rg2(R) vs. Rg2(S)), as demonstrated by UHPLC-MS/MS of 26 ginsenosides.
Fig.4 UHPLC‑MS/MS TIC chromatogram of 26 ginsenosides on HSS T3 C18 column: 1; Re, 2; Rg1, 3; Rf, 4; Rg2(S), 5; F3, 6; Rh1(S), 7; Rg2(R), 8; Rh1(R), 9; F1, 10; Rb1, 11; Rc, 12; Rb2, 13; F4, 14; Rg6, 15; Rd, 16; PPT(S), 17; XVII, 18; Rg3(S), 19; Rg3(R), 20; F2, 21; Mc, 22; Y, 23; Rg5, 24; K, 25; Rh2(S), 26; Rh2(R), HSS T3 C18 column (2.1 x 50 mm, 1.8 μm)[4].
Why Do We Need Method Validation and Quantification?
- Quality Control and Product Claim Impact
Accurate quantification is essential because the biological activity of each ginsenoside monomer differs significantly: for instance, ginsenosides Rb1, Rb2, Rc, and Rd are usually present as > 70% of total ginsenosides in ginseng.
Quantification errors may result in mislabeling of the active ingredient, regulatory non-compliance, or diminished effectiveness.
- Sensitivity, Specificity, and Matrix Effects
The matrix (plant material, extracts, plasma) can interfere with detection (ion suppression/enhancement in the mass spectrometer), coelution of impurities can cause quantitative bias, and stereoisomers can coelute. For example, a human plasma pharmacokinetic study of 13 ginsenosides had an LLOQ of 0.5 ng/mL for all analytes.
- Regulatory Standardization and Marker Analysis
Some pharmacopoeias or regulatory agencies report the contents of specific monomers (e.g., Rg1, Re, Rb1) as markers of ginseng quality. Validated methods aid in ensuring regulatory compliance and product integrity.
- Isomer Separation and Characterization
As mentioned above, stereoisomers and positional isomers need to be separated due to potential differences in activity. The UHPLC-MS/MS method separated 26 ginsenosides (including a combination of four stereoisomers) in 26 minutes, setting a benchmark.
How to Design a Robust Ginsenoside Monomer Detection Workflow
| 1. Determine Monomer List and Specifications | First, identify the ginsenoside monomers to be quantified (e.g., Rb1, Rb2, Rc, Rd, Re, Rg1, Rg3, Rh2, F1, CK). This list depends on the product type (white ginseng, red ginseng, or extract) and regulatory/functional requirements. |
| 2. Select Extraction Method and Optimize Sample Preparation |
|
| 3. Establish Chromatographic Separation System |
|
| 4. Configure Spectral Detection |
|
| 5. Method Validation | According to standard protocols, verify:
|
Elucidating the structure, chromatographic behavior and spectral characteristics of ginsenoside monomers is of great significance to the research on the chemistry, pharmacology, and product quality of ginseng. Their structural characteristics and stereochemistry, chromatographic separation, and spectral identification information provide a more intuitive basis for understanding the individual ginsenosides and the types that appear and disappear in different processing methods or during metabolism.
Clients exploring melitracen hydrochloride may also find value in our following products:
References
- Qian J, et al. Ginsenosides: an immunomodulator for the treatment of colorectal cancer. Front Pharmacol.(2024).
- Huang Q, et al. Review of ginsenosides targeting mitochondrial function to treat multiple disorders: Current status and perspectives. Journal of Ginseng Research.(2020).
- Li K-K, et al. Isolation, Purification and Quantification of Ginsenoside F5 and F3 Isomeric Compounds from Crude Extracts of Flower Buds of Panax ginseng. Molecules.(2016).
- Lee J, et al. A rapid, simultaneous and quantitative analysis of 26 ginsenosides in white and red Panax ginseng using LC–MS/MS. Applied Biological Chemistry.(2021).
Please kindly note that our products are for research use only.
